Edition:
United Kingdom

Amarin Corporation PLC (AMRN.OQ)

AMRN.OQ on NASDAQ Stock Exchange Global Market

20.63USD
17 Oct 2018
Change (% chg)

-- (--)
Prev Close
$20.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,809,001
52-wk High
$21.04
52-wk Low
$2.36

Chart for

About

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule,... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $950.48
Shares Outstanding(Mil.): 270.79
Dividend: --
Yield (%): --

Financials

  AMRN.OQ Industry Sector
P/E (TTM): -- 85.83 33.69
EPS (TTM): -0.31 -- --
ROI: -101.25 0.58 14.30
ROE: -- 1.62 16.03

BRIEF-Amarin Corporation Reports Q1 GAAP Loss Per Share $0.08

* REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES UPDATE ON OPERATIONS

02 May 2018

Competitors

Earnings vs. Estimates